Fushine(SZ:300497) Xin Lang Cai Jing·2025-10-28 01:35Core Insights - Fuxiang Pharmaceutical (300497.SZ) released its Q3 2025 report on October 28, 2025, indicating a total of 6 institutional investors holding shares, amounting to 34.4275 million shares, which represents 6.39% of the total share capital [1] Institutional Holdings - The institutional investors include Qingdao Hengze Rui Fund Management Co., Ltd., Jingdezhen Fuxiang Investment Co., Ltd., Jingdezhen Guokong Financial Development Co., Ltd., Guangzhou Fengshen Automotive Investment Group Co., Ltd., CITIC Jiantou Securities Co., Ltd., and Gongqingcheng Yunfeng Asset Management Co., Ltd. - Yunfeng Value No. 5 Securities Investment Private Fund [1] - The total institutional holding percentage decreased by 1.97 percentage points compared to the previous quarter [1] Public Fund Disclosures - In this period, 27 public funds were not disclosed compared to the previous quarter, including funds such as China Merchants Medical Health Industry Stock, China Merchants Quality Growth Mixed A, China Merchants Frontier Medical Care Stock A, China Merchants Innovation Growth Mixed A, and Bosera Huixing Return One-Year Holding Period Mixed [1]